Serveur d'exploration Tocilizumab - Merge (Accueil)

Index « Auteurs » - entrée « Hiroaki Dobashi »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hiroaki Azukizawa < Hiroaki Dobashi < Hiroaki Harada  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
001F70 (2015) Atsushi Ogata ; Koichi Amano ; Hiroaki Dobashi ; Masayuki Inoo ; Tomonori Ishii ; Tsuyoshi Kasama ; Shinichi Kawai ; Atsushi Kawakami ; Tatsuya Koike ; Hisaaki Miyahara ; Toshiaki Miyamoto ; Yasuhiko Munakata ; Akira Murasawa ; Norihiro Nishimoto ; Noriyoshi Ogawa ; Tomohiro Ojima ; Hajime Sano ; Kenrin Shi ; Eisuke Shono ; Eiichi Suematsu ; Hiroki Takahashi ; Yoshiya Tanaka ; Hiroshi Tsukamoto ; Akira NomuraLongterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study.
002014 (2015) Ryoko Sakai [Japon] ; Soo-Kyung Cho [Japon] ; Toshihiro Nanki [Japon] ; Kaori Watanabe [Japon] ; Hayato Yamazaki [Japon] ; Michi Tanaka [Japon] ; Ryuji Koike [Japon] ; Yoshiya Tanaka [Japon] ; Kazuyoshi Saito [Japon] ; Shintaro Hirata [Japon] ; Koichi Amano [Japon] ; Hayato Nagasawa [Japon] ; Takayuki Sumida [Japon] ; Taichi Hayashi [Japon] ; Takahiko Sugihara [Japon] ; Hiroaki Dobashi [Japon] ; Shinsuke Yasuda [Japon] ; Tetsuji Sawada [Japon] ; Kazuhiko Ezawa [Japon] ; Atsuhisa Ueda [Japon] ; Takao Fujii [Japon] ; Kiyoshi Migita [Japon] ; Nobuyuki Miyasaka [Japon] ; Masayoshi Harigai [Japon]Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry.
003598 (2012) Ryoko Sakai [Japon] ; Michi Tanaka [Japon] ; Toshihiro Nanki [Japon] ; Kaori Watanabe [Japon] ; Hayato Yamazaki [Japon] ; Ryuji Koike [Japon] ; Hayato Nagasawa [Japon] ; Koichi Amano [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Satoshi Ito [Japon] ; Takayuki Sumida [Japon] ; Atsushi Ihata [Japon] ; Yoshiaki Ishigatsubo [Japon] ; Tatsuya Atsumi [Japon] ; Takao Koike [Japon] ; Atsuo Nakajima [Japon] ; Naoto Tamura [Japon] ; Takao Fujii [Japon] ; Hiroaki Dobashi [Japon] ; Shigeto Tohma [Japon] ; Takahiko Sugihara [Japon] ; Yukitaka Ueki [Japon] ; Akira Hashiramoto [Japon] ; Atsushi Kawakami [Japon] ; Noboru Hagino [Japon] ; Nobuyuki Miyasaka [Japon] ; Masayoshi Harigai [Japon]Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules
003876 (2012) Ryoko Sakai [Japon] ; Michi Tanaka [Japon] ; Toshihiro Nanki [Japon] ; Kaori Watanabe [Japon] ; Hayato Yamazaki [Japon] ; Ryuji Koike [Japon] ; Hayato Nagasawa [Japon] ; Koichi Amano [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Satoshi Ito [Japon] ; Takayuki Sumida [Japon] ; Atsushi Ihata [Japon] ; Yoshiaki Ishigatsubo [Japon] ; Tatsuya Atsumi [Japon] ; Takao Kolke [Japon] ; Atsuo Nakajima [Japon] ; Naoto Tamura [Japon] ; Takao Fujii [Japon] ; Hiroaki Dobashi [Japon] ; Shigeto Tohma [Japon] ; Takahiko Sugihara [Japon] ; Yukitaka Ueki [Japon] ; Akira Hashiramoto [Japon] ; Atsushi Kawakami [Japon] ; Noboru Hagino [Japon] ; Nobuyuki Miyasaka [Japon] ; Masayoshi Harigai [Japon]Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "Hiroaki Dobashi" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i  \
                -Sk "Hiroaki Dobashi" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    Author.i
   |clé=    Hiroaki Dobashi
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021